---

$3.42

-0.0350 ( -1.30% ) 239.9K

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Analyst Insights

---

You need to login to view this content.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-09-13	Buy	100000.00	CASCELLA ROBERT
2024-09-06	Buy	25000.00	MUIR GLENN P
2024-08-30	Buy	12776.00	MUIR GLENN P
2024-08-21	Buy	25000.00	MUIR GLENN P
2024-08-19	Buy	35000.00	CASCELLA ROBERT
2024-08-16	Buy	25171.00	MUIR GLENN P
2024-08-16	Buy	35000.00	CASCELLA ROBERT
2024-07-22	Sale	-24162.00	Sullivan Keith J
2024-07-18	Sale	-12075.00	Sullivan Keith J
2024-06-06	Buy	50000.00	CASCELLA ROBERT

Reset

Symbol	Issuer Name	Market Value ↓	Share Quantity
No records found.